Consolidated Statements of Changes in Shareholders' Equity - USD ($)	Common Stock [Member]	Additional Paid-in Capital [Member]	Subscription Receivable [Member]	Retained Earnings [Member]	AOCI Attributable to Parent [Member]	Total
Balance at Dec. 31, 2023	$ 152	$ 100,843,091	$ (1,817,640)	$ (96,499,518)	$ (569,749)	$ 1,956,336
Beginning balance, shares at Dec. 31, 2023	15,219
Issuance of common shares for vested RSU	$ 1	(1)
Issuance of common shares for vested RSU, shares	153					1,216
Exercise of Inducement Warrants for common stock	$ 109	2,676,871				$ 2,676,980
Exercise of Inducement Warrants for Common Stock, shares	10,856
Stock based compensation		1,562,392				1,562,392
Foreign exchange translation loss					(24,768)	(24,768)
Net loss				(9,574,987)		(9,574,987)
Common stock sold under the Equity Distribution Agreement, net of offering costs of $583,713	$ 93	1,808,696				1,808,789
Common Stock sold under the Equity Distribution Agreement, net of offering costs of $583,713, shares	9,267
Issuance of direct offering shares (see Note 7)	$ 38	771,255				771,293
Issuance of direct offering shares, shares	3,816
Proceeds from the subscription receivable related to the issuance of Inducement Warrants, net of offering costs of $12,821		(12,821)	280,500			267,679
Proceeds from the subscription receivable related to the exercise of warrants and preferred investment options and issuance of common stock in abeyance	$ 39	(39)	1,537,140			1,537,140
Proceeds from the subscription receivable related to the exercise of warrants and preferred investment options and issuance of Common Stock in abeyance, shares	3,912
Common stock sold under the Purchase Agreement, net of offering costs of $471,756	$ 133	611,820				611,953
Common Stock sold under the Purchase Agreement, net of offering costs, shares	13,278
Balance at Dec. 31, 2024	$ 565	108,261,264		(106,074,505)	(594,517)	1,592,807
Balance, shares at Dec. 31, 2024	56,501
Issuance of Common Stock and Series A and B and prefunded warrants for cash, net of offering costs of $755,487	$ 1,024	4,243,443				4,244,467
Issuance of Common Stock and Series A and B and prefunded warrants for cash, net of offering costs of $755,487, shares	102,444
Issuance of common shares for vested RSU	$ 393	(393)
Issuance of common shares for vested RSU, shares	39,380					1,274
Exercise of Inducement Warrants for common stock	$ 385	74,659				$ 75,044
Exercise of Inducement Warrants for Common Stock, shares	38,528
Issuance of round up shares	$ 860	(860)
Issuance of round up shares, shares	85,965
Issuance of common shares for cash pursuant to ATM Agreement, net of offering costs of $217,079	$ 1,103	1,635,696				1,636,799
Issuance of common shares for cash pursuant to ATM Agreement, net of offering costs, shares	110,242
Exercise of Series A, B, C, and D Warrants for common shares, net of offering costs of $988,911	$ 6,285	4,552,324				4,558,609
Exercise of Series A and B Warrants for common shares, net of offering costs of $424,659, shares	628,473
Deemed dividend on inducement of warrants of $3,359,485
Stock based compensation		827,323				827,323
Foreign exchange translation loss					14,479	14,479
Net loss				(8,771,987)		(8,771,987)
Balance at Dec. 31, 2025	$ 10,615	$ 119,593,456		$ (114,846,492)	$ (580,038)	$ 4,177,541
Balance, shares at Dec. 31, 2025	1,061,533